Back
Heron Therapeutics Stock Price Chart
Supercharge Your Portfolio with This High-Traction AI Startup
Learn More
Sell
25
HRTX
Heron Therapeutics
Last Price:
2.13
Seasonality Move:
-0.18%
7 Day Trial
ALL ACCESS PASS
$
7
AI Tech Innovator Poised for Strategic Buyouts Invest Now
Learn More- The current trend is relatively stagnant and HRTX is experiencing slight buying pressure.
Heron Therapeutics Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 2.03 | Buy |
| 20-day SMA: | 1.95 | Buy |
| 50-day SMA: | 2.08 | Buy |
| 200-day SMA: | 2.61 | Sell |
| 8-day EMA: | 2.04 | Buy |
| 20-day EMA: | 2 | Buy |
| 50-day EMA: | 2.16 | Sell |
| 200-day EMA: | 2.43 | Sell |
Heron Therapeutics Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0 | Buy |
| Relative Strength Index (14 RSI): | 57.11 | Buy |
| Chaikin Money Flow: | 533494 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (1.81 - 2.03) | Buy |
| Bollinger Bands (100): | (2.01 - 3.41) | Sell |
Heron Therapeutics Technical Analysis
| Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | Sep 30 | Oct 1 | Oct 2 | Oct 3 | Oct 4 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | Oct | |||||||||
| 23 | 24 | 25 | 26 | 27 | 30 | 01 | 02 | 03 | 04 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Heron Therapeutics Stock
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.12 while HRTX 8-day simple moving average is 2.03, which is a Buy signal.
- The stock price of HRTX is 2.12 while Heron Therapeutics 20-day SMA is 1.95, which makes it a Buy.
- Heron Therapeutics 50-day simple moving average is 2.08 while HRTX share price is 2.12, making it a Buy technically.
- HRTX stock price is 2.12 and Heron Therapeutics 200-day simple moving average is 2.61, creating a Sell signal.
HRTX Technical Analysis vs Fundamental Analysis
Sell
25
Heron Therapeutics (HRTX)
is a Sell
Is Heron Therapeutics a Buy or a Sell?
-
Heron Therapeutics stock is rated a Sell
The current Heron Therapeutics [HRTX] share price is $2.12. The Score for HRTX is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
Heron Therapeutics Stock Info
Market Cap:
321.54M
Price in USD:
2.12
Share Volume:
1.33M
Heron Therapeutics 52-Week Range
52-Week High:
3.93
52-Week Low:
0.50
Sell
25
Heron Therapeutics (HRTX)
is a Sell
Heron Therapeutics Share Price Forecast
-
What is the Heron Therapeutics stock price today?
The Heron Therapeutics stock price is 2.12 USD today. -
Will HRTX stock go up or go down?
Heron Therapeutics> share price is forecast to RISE/FALL based on technical indicators -
Is Heron Therapeutics overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Heron Therapeutics is overvalued.
Is Heron Therapeutics Stock a Buy?
- Heron Therapeutics share price is 2.12 while HRTX 8-day exponential moving average is 2.04, which is a Buy signal.
- The stock price of HRTX is 2.12 while Heron Therapeutics 20-day EMA is 2.00, which makes it a Buy.
- Heron Therapeutics 50-day exponential moving average is 2.16 while HRTX share price is 2.12, making it a Sell technically.
- HRTX stock price is 2.12 and Heron Therapeutics 200-day simple moving average is 2.43, creating a Sell signal.
Fundamental Analysis of Heron Therapeutics
Is Heron Therapeutics a good investment?
- Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.74 per share, and an increase next year of $0.13 per share.
Technical Analysis of Heron Therapeutics
Should I short Heron Therapeutics stock?
- HRTX Moving Average Covergence Divergence (MACD) indicator is 0, suggesting Heron Therapeutics is a Buy
- Heron Therapeutics Relative Strength Index (RSI) is 57.11, which suggest Heron Therapeutics is overbought
- The Bollinger Bands (25) for Heron Therapeutics is (1.81 - 2.03), which suggest Heron Therapeutics is a Sell
- The Bollinger Bands (100) for Heron Therapeutics is (2.01 - 3.41), which suggest Heron Therapeutics is a Sell
* Heron Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.